Reuters logo
BRIEF-PCI Biotech: extension of preclinical research collaboration agreement
July 10, 2017 / 6:17 AM / 2 months ago

BRIEF-PCI Biotech: extension of preclinical research collaboration agreement

July 10 (Reuters) - PCI BIOTECH HOLDING ASA:

* REG-PCI BIOTECH: EXTENSION OF PRECLINICAL RESEARCH COLLABORATION AGREEMENT WITH A TOP-10 LARGE PHARMA COMPANY

* ANNOUNCED THAT THEY ARE EXTENDING PRECLINICAL RESEARCH COLLABORATION WITH AN UNDISCLOSED TOP-10 PHARMA COMPANY, INITIATED IN SEPTEMBER 2015

* EXTENDED EVALUATION PERIOD SPANS OVER SIX MONTHS, UNTIL END OF 2017, AND MAY BE FURTHER EXTENDED

* PHARMA COMPANY IS ONE OF GLOBAL LEADERS IN NUCLEIC ACID THERAPEUTICS

* COMPANIES WILL EVALUATE DATA GENERATED IN THIS RESEARCH COLLABORATION AND EXPLORE POTENTIAL FOR A FURTHER PARTNERSHIP BASED ON THIS OUTCOME Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below